Innomar Strategies is a Canadian company that specializes in providing patient support for specialty pharmaceuticals as part of Cencora. Established in 2001, the company offers comprehensive solutions to enhance product access, streamline supply chain efficiency, and elevate patient care within the Biotechnology and Pharmaceutical industries. Their services include strategic consulting, patient assistance programs, nursing and clinical services, specialty pharmacy, and logistics. Innomar Strategies collaborates closely with manufacturers, healthcare providers, pharmacies, and payers to ensure consistent and reliable access to specialty medication for patients.
With an integrated approach and dedication to providing top-notch care, Innomar Strategies ensures that patients receive unwavering support throughout their treatment journey. Despite the absence of recent public investment information, the company's strong market presence and focus on improving patient outcomes make it an intriguing prospect for potential venture capital investment.
There is no investment information
No recent news or press coverage available for Innomar Strategies.
We care about your data, and we'd love to use cookies make your experience better.
